Mercy Bioanalytics News Today

/PRNewswire/ -- InsightAce Analytic Pvt. Ltd. announces the release of the market assessment report on "Global EV-based Liquid Biopsy Market Size, Share &...

Large for-profit life sciences companies have called Central Mass. their home for decades. Now, they play an important role in bringing talent, investment, and research to the region.

Mercy BioAnalytics, a life sciences company born in Cambridge and now based in Natick, has closed a $41 million Series A financing round.

Nearly 40 venture firms, from Andreessen Horowitz to Craft Ventures to Techstars, have accepted money from Saudi Arabia’s sovereign wealth fund.

The proceeds will help develop and commercialize its extracellular vesicle-based Mercy Halo platform for lung, ovarian, and other cancer screening tests.

Mercy BioAnalytics closed a $41 million Series A financing that will be used to further the development of the company’s novel Mercy Halo test.

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Mercy BioAnalytics, Inc. promoted its chief operating officer, Dawn Mattoon, to the CEO position. Former CEO and Co-founder Paul Blavin transitioned to vice chairman of the board.

Mercy BioAnalytics Appoints Dawn Mattoon, PhD, as Chief Operating Officer - read this article along with other careers information, tips and advice on BioSpace

ABI-LAB offers flexibility and affordability outside major hubs like Boston and Cambridge for life science and Biotech companies.